Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
July 31, 2024
Already have an account?
This interview features Alex Del Priore, senior vice president of manufacturing services, Syngene International, who discussed the company's production contract with animal health company Zoetis to manufacture the drug substance for Librela (bedinvetmab), a mAb used to treat osteoarthritis pain in dogs, while also expanding manufacturing capabilities.
Register or Login and hit Watch on Demand to view the recorded interview now.
You May Also Like